Fig. 1
From: SYVN1 modulates papillary thyroid carcinoma progression by destabilizing HMGB1
SYVN1 is significantly decreased in PTC tissues and cells. (A) RT-PCR and (E) WB were used to measure the mRNA and protein expression levels of SYVN1 on 10 paired human PTC samples and non-tumor thyroid tissues. (C) Representative IHC staining of SYVN1 in PTC tissues. (D) RT-PCR quantified SYVN1 mRNAs. (E) Differential expression of SYVN1 protein was compared in PTC cells